Loading...
Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial
Moreno, V. Barretina-Ginesta, M. P. García-Donas, J. Jayson, Gordon C Roxburgh, P. Vázquez, R. M. Michael, A. Antón-Torres, A. Brown, R. Krige, D.
Moreno, V.
Barretina-Ginesta, M. P.
García-Donas, J.
Jayson, Gordon C
Roxburgh, P.
Vázquez, R. M.
Michael, A.
Antón-Torres, A.
Brown, R.
Krige, D.
Citations
Altmetric:
Abstract
Description
Date
2021
Publisher
Collections
Files
Loading...
From UNPAYWALL
Adobe PDF, 1.98 MB
Keywords
Type
Article
Citation
Moreno V, Barretina-Ginesta M-P, García-Donas J, Jayson GC, Roxburgh P, Vázquez RM, et al. Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial Vol. 9, Journal for ImmunoTherapy of Cancer. BMJ; 2021. p. e003645.